Skip to main content

Table 4 Positive Predictive Values (PPV) of self-reported breast cancer characteristics stratified by age at diagnosis, Sister Study 2003-2014a

From: Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer

 

35–54 (n = 536)

55–64 (n = 744)

≥65 (n = 728)

Breast cancer characteristic

Medical record (%)b

Self-report (%)b

PPV (%)

Medical record (%)b

Self-report      (%)b

PPV (%)

Medical record (%)b

Self-report   (%)b

PPV (%)

Invasiveness

 Invasive

396 (74)

340 (65)

99.4

554 (75)

448 (63)

99.3

583 (80)

403 (60)

99.3

 In situ

139 (26)

181 (35)

75.1

188 (25)

263 (37)

69.7

145 (20)

267 (40)

51.3

 Unknown

1

15

 

2

33

 

0

58

 

Locationc

 Ductal (any)

467 (88)

426 (85)

98.6

669 (90)

586 (88)

99.1

668 (92)

550 (90)

98.9

 Lobular only

64 (12)

76 (15)

76.0

71 (10)

78 (12)

76.9

55 (8)

61 (10)

73.8

 Unknown

3

32

 

2

78

 

4

116

 

Stage

 0

139 (26)

159 (32)

78.0

187 (25)

214 (33)

75.5

145 (20)

190 (31)

60.5

 I

241 (45)

183 (37)

92.8

367 (50)

258 (39)

91.9

427 (59)

271 (45)

91.9

 II

116 (22)

114 (23)

71.1

141 (19)

134 (20)

67.2

123 (17)

104 (17)

65.4

 III/IV

38 (7)

37 (8)

75.7

46 (6)

52 (8)

73.1

33 (5)

39 (6)

64.1

 Unknown

2

43

 

3

86

 

0

124

 

Among medically confirmed invasive cases:d

 ER

  Positive

322 (84)

305 (81)

98.7

454 (83)

406 (82)

99.0

501 (89)

393 (85)

99.5

  Negative

63 (16)

73 (19)

82.6

90 (17)

92 (18)

87.6

64 (11)

69 (15)

77.3

  Unknown

11

18

 

10

56

 

18

121

 

 PR

  Positive

293 (76)

207 (65)

99.5

375 (69)

213 (57)

99.1

413 (74)

223 (64)

98.2

  Negative

91 (24)

112 (35)

69.7

166 (31)

163 (43)

72.0

147 (26)

127 (36)

73.0

  Unknown

12

77

 

13

178

 

23

233

 

 HER2

  Positive

49 (13)

64 (20)

71.7

65 (12)

90 (23)

67.0

53 (10)

78 (22)

60.0

  Negative

324 (87)

263 (80)

98.0

458 (88)

310 (78)

100

490 (90)

272 (78)

99.2

  Unknown

23

69

 

31

154

 

40

233

 
  1. Abbreviation: PPV positive predictive value, ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2
  2. aExcludes 43 who did not complete the questionnaire about breast cancer characteristics and 3 who reported on a different breast cancer event than the one abstracted from her medical records
  3. bData are reported as number (percentage) of women. Totals may not always equal 100% because of rounding
  4. cExcludes 5 cases that are not of ductal or lobular origin (phyllodes tumors)
  5. dER, PR, and HER2 analyses are restricted to 1533 cases (35–54: n = 396; 55–64: n = 554; ≥65: n = 583) confirmed as invasive breast cancer by medical records